This project aims to determine how human lung epithelial homeostasis is regulated in acute lung injury induced by the 2009 H1N1 pandemic influenza virus. Because of the rapid transmission and high potential for increased pathogenicity of the H1N1 pandemic virus, there is an urgent need to understand the host response against viral infection. This virus targets distal lung cells and causes more severe disease than seasonal influenza virus, including diffuse alveolar damage and pulmonary edema. To define the mechanism of this tissue injury, it is important to study the specific cells that are infected by te virus. Therefore, our studies will focus on the cells in the alveolar region of the human lung. Our approach is novel in that we will study the effect of 2009 H1N1 pandemic virus on primary cultures of human alveolar epithelial cells and alveolar macrophages isolated from the same healthy lung donors. We have preliminary data using this system that suggests the involvement of both the AIM2 inflammasome and the cytokine TSLP in host response to influenza virus infection.
The AIM2 inflammasome is important for host defense against bacteria and DNA virus infection, but a role for it in RNA virus infection has not previously been identified. Here we wil determine the function and mechanism of the AIM2 inflammasome in primary human ATII cells and in a mouse model during H1N1 influenza-induced epithelial injury. We hypothesize that AIM2 is the primary inflammasome induced by influenza virus in alveolar epithelial cells.
AIM2 deficient cells and AIM2 deficient mice will have more impairment of the epithelial barrier during influenza infection. TSLP plays a key role in allergic diseases such as asthma, but its effect on the epithelial barrier is not yet defined. We will determine the role of TSLP in protecting the alveolar epithelial barrier during influenza infection using both in vitro and in vivo models. We hypothesize that inflammasome activation will enhance the TSLP production by alveolar epithelial cells. Influenza-stimulated TSLP will improve the damaged barrier by influenza both in vitro and in vivo through enhancing the tight junctions between cells and/or stimulating epithelial proliferation. In addition, the cell-cell interaction between alveolar epithelial cells and macrophages will enhance the release of TSLP by epithelial cells. Our study will reveal novel mechanisms for the regulation of the alveolar epithelial barrier during acute lung injury by influenza, thereby uncovering potential novel therapeutic strategies for reducing influenza-induced mortality.

Public Health Relevance

Influenza is a common public health problem. It causes more than 35,000 deaths, 200,000 hospitalizations, and more than $37.5 billion in economic loss (www.cdc.gov). Recently, 2009 H1N1 pandemic virus led to over 18,000 verified deaths according to the WHO. The gas exchange cells deep within the human lung are the primary targets for 2009 H1N1 pandemic virus. We propose to study the regulation of the influenza-induced innate immune response with a focus on the epithelial barrier. By studying influenza infection in human lung alveolar epithelial cells and alveolar macrophages, our proposed studies aim to identify the regulation mechanism of lung epithelial homeostasis during influenza-induced acute lung injury and to reveal novel therapeutic agents to protect the epithelial barrier, therefore reducing influenza-induced mortality.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL113655-02
Application #
8459947
Study Section
Lung Injury, Repair, and Remodeling Study Section (LIRR)
Program Officer
Harabin, Andrea L
Project Start
2012-04-15
Project End
2017-02-28
Budget Start
2013-03-01
Budget End
2014-02-28
Support Year
2
Fiscal Year
2013
Total Cost
$377,230
Indirect Cost
$139,230
Name
National Jewish Health
Department
Type
DUNS #
076443019
City
Denver
State
CO
Country
United States
Zip Code
80206
Tang, Xinying; Zhang, Hongbo; Song, Yufeng et al. (2016) Hemagglutinin-targeting Artificial MicroRNAs Expressed by Adenovirus Protect Mice From Different Clades of H5N1 Infection. Mol Ther Nucleic Acids 5:e311
Hidvegi, Tunda; Stolz, Donna B; Alcorn, John F et al. (2015) Enhancing Autophagy with Drugs or Lung-directed Gene Therapy Reverses the Pathological Effects of Respiratory Epithelial Cell Proteinopathy. J Biol Chem 290:29742-57
Otsubo, Chikara; Bharathi, Sivakama; Uppala, Radha et al. (2015) Long-chain Acylcarnitines Reduce Lung Function by Inhibiting Pulmonary Surfactant. J Biol Chem 290:23897-904
Li, Li; Hamzeh, Nabeel; Gillespie, May et al. (2015) Beryllium increases the CD14(dim)CD16+ subset in the lung of chronic beryllium disease. PLoS One 10:e0117276
Travanty, Emily; Zhou, Bin; Zhang, Hongbo et al. (2015) Differential Susceptibilities of Human Lung Primary Cells to H1N1 Influenza Viruses. J Virol 89:11935-44
Zhou, Bin; Pearce, Melissa B; Li, Yan et al. (2013) Asparagine substitution at PB2 residue 701 enhances the replication, pathogenicity, and transmission of the 2009 pandemic H1N1 influenza A virus. PLoS One 8:e67616
Qian, Zhaohui; Travanty, Emily A; Oko, Lauren et al. (2013) Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus. Am J Respir Cell Mol Biol 48:742-8
Macleod, Megan K L; David, Alexandria; Jin, Niyun et al. (2013) Influenza nucleoprotein delivered with aluminium salts protects mice from an influenza A virus that expresses an altered nucleoprotein sequence. PLoS One 8:e61775
Wu, Qun; Case, Stephanie R; Minor, Maisha N et al. (2013) A novel function of MUC18: amplification of lung inflammation during bacterial infection. Am J Pathol 182:819-27
Kosmider, Beata; Messier, Elise M; Janssen, William J et al. (2012) Nrf2 protects human alveolar epithelial cells against injury induced by influenza A virus. Respir Res 13:43

Showing the most recent 10 out of 11 publications